LEMAITRE VASCULAR, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.46 USD | +3.92% |
|
+3.48% | +15.33% |
| Apr. 26 | Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59 | MT |
| Mar. 12 | Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing | MT |
Presentation Operator MessageOperator (Operator)Welcome to the LeMaitre Vascular Q3 2023 Finan...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Companyâs principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.
Calendar
2024-05-02
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
65.46
USD
Average target price
73.57
USD
Spread / Average Target
+12.39%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.33% | 1.47B | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- LMAT Stock
- News LeMaitre Vascular, Inc.
- Transcript : LeMaitre Vascular, Inc., Q3 2023 Earnings Call, Nov 01, 2023
